Old names:
| Owner | Filings | Transaction Date | Type of Owner |
|---|---|---|---|
| Barat Stephen | 0001965244 | Feb-02-2023 | officer: Senior VP of Therapeutics |
| Dubensky Thomas W. | 0001635590 | Aug-18-2022 | director |
| L5 Capital Inc. | 0001869759 | Jul-15-2022 | 10 percent owner |
| KIRITSY CHRISTOPHER P | 0001261156 | Jan-27-2022 | director |
| Lawson Byron | 0001801387 | Jan-23-2020 | officer: SVP/Chief Commercial Officer |
| LYTTON LAURENCE W | 0001105806 | Sep-20-2019 | 10 percent owner |
| Godlewski Laura Lee | 0001778044 | May-23-2019 | officer: VP of Accounting and Reporting |
| GRIFFIN MICHELLE RENEE | 0001229765 | Aug-15-2018 | director |
| QIAGEN NV | 0001015820 | Nov-17-2016 | 10 percent owner |
| HANHAM ANN | 0001286338 | Aug-25-2016 | director |
| HARDISON DON M | 0001209588 | May-02-2016 | director |
| LAFRANCE JAMES T | 0001162956 | Dec-01-2015 | director |
| McCracken Lee R. | 0001493321 | Oct-27-2015 | director |
| GRIMM DONALD W | 0001208809 | May-11-2015 | director |
| GLAXOSMITHKLINE PLC | 0001131399 | May-05-2015 | 10 percent owner |
| JOHNSON TIM B | 0001194674 | May-05-2015 | director, officer: President & CEO |
| McMeans Shaun D | 0001316705 | May-05-2015 | officer: VP, Finance & Admin. & CFO |
| FSV II LP | 0001384327 | May-05-2015 | 10 percent owner |
| Fletcher Spaght Ventures II LP | 0001384348 | May-05-2015 | 10 percent owner |
| Novo A/S | 0001388325 | May-05-2015 | 10 percent owner |
| FSV II-B LP | 0001433420 | May-05-2015 | 10 percent owner |
| Shuster Lewis | 0001471131 | May-05-2015 | director |
| George Simeon | 0001595117 | May-05-2015 | director |
| Bisgaard Peter | 0001606387 | May-05-2015 | director |
| Senour Lawrence D. | 0001623206 | May-05-2015 | 10 percent owner |
| Hoult Mary | 0001623212 | May-05-2015 | director |
| Roche Patrick C. | 0001623213 | May-05-2015 | officer: SVP Research & Development |
| Gordon Debra A | 0001623214 | May-05-2015 | officer: V.P. and Chief Legal Counsel |
| Merck Capital Ventures LLC | 0001623584 | May-05-2015 | 10 percent owner |
| Lubniewski John L | 0001623587 | May-05-2015 | officer: Chief Business Officer |
| George Harry A. | 0001628346 | May-05-2015 | director |
Coming soon!
Coming soon!
Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by HTG MOLECULAR DIAGNOSTICS, INC
| Filings | Format | Description | Filed/Effective | File/Film Number |
|---|---|---|---|---|
| 25-NSE | Document | Acc-no: 0001354457-23-000488 (34 Act) Size: KB | Jul-10-2023 | |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001209191-23-036100 ( Act) Size: 0 KB |
Jun-09-2023 | |
| 8-K | Document | Current report filing Acc-no: 0000950170-23-027044 (34 Act) Size: KB |
Jun-08-2023 | 231002645 |
| 8-K | Document | Current report filing Acc-no: 0000950170-23-026337 (34 Act) Size: KB |
Jun-05-2023 | 23992277 |
| 8-K | Document | Current report filing Acc-no: 0000950170-23-023963 (34 Act) Size: KB |
May-24-2023 | 23954940 |
| 8-K | Document | Current report filing Acc-no: 0000950170-23-022358 (34 Act) Size: KB |
May-16-2023 | 23925724 |
| 10-Q | Document | Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0000950170-23-020725 (34 Act) Size: KB |
May-11-2023 | 23908257 |
| 8-K | Document | Current report filing Acc-no: 0000950170-23-020671 (34 Act) Size: KB |
May-10-2023 | 23907806 |
| 8-K | Document | Current report filing Acc-no: 0000950170-23-014248 (34 Act) Size: KB |
Apr-25-2023 | 23841800 |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001209191-23-023774 ( Act) Size: 0 KB |
Apr-07-2023 | |
| 10-K | Document | Annual report pursuant to section 13 and 15(d) Acc-no: 0000950170-23-010975 (34 Act) Size: KB |
Mar-30-2023 | 23781154 |
| SC 13G/A | Document | Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0000935836-23-000183 (34 Act) Size: KB |
Feb-13-2023 | 23617793 |
| 3 | Document | Initial statement of beneficial ownership of securities Acc-no: 0001209191-23-008420 ( Act) Size: 0 KB |
Feb-10-2023 | |
| SC 13G/A | Document | Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0000919574-23-000851 (34 Act) Size: KB |
Feb-10-2023 | 23608764 |
| 8-K | Document | Current report filing Acc-no: 0000950170-23-001781 (34 Act) Size: KB |
Feb-03-2023 | 23586472 |
| SC 13G | Document | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0000890163-23-000011 (34 Act) Size: KB |
Feb-03-2023 | 23585685 |
| 8-K | Document | Current report filing Acc-no: 0000950170-23-000286 (34 Act) Size: KB |
Jan-06-2023 | 23513806 |
| 8-K | Document | Current report filing Acc-no: 0000950170-22-027080 (34 Act) Size: KB |
Dec-29-2022 | 221496349 |
| 8-K | Document | Current report filing Acc-no: 0000950170-22-027014 (34 Act) Size: KB |
Dec-23-2022 | 221485723 |
| 424B4 | Document | Prospectus filed pursuant to Rule 424(b)(4) Acc-no: 0001193125-22-311164 (33 Act) Size: KB |
Dec-22-2022 | 221482694 |
Recent 20 filings. View all HTG MOLECULAR DIAGNOSTICS, INC filings
Thanks I look forward to using the product to improve my skin tone
Very good communication and delivery made within the timeframe I was advised of
young lad who new his job ansered questions and new what was best for me.
Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.
© 2022 CompaniesBIO.Com. All rights reserved. Operated by